Cao Chen
Overview
Explore the profile of Cao Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
1743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao L, Zheng C, Tian T, Brima Tia A, Abdulai M, Xiao K, et al.
Front Public Health
. 2025 Mar;
13:1526727.
PMID: 40051513
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has caused significant public health and socioeconomic crises across Africa; however, the prevalent patterns of COVID-19 and the circulating characteristics of severe acute...
2.
Zhang W, Wang Y, A R, Liang D, Xiao K, Zhou D, et al.
China CDC Wkly
. 2025 Feb;
7(7):253-260.
PMID: 39974763
What Is Already Known About This Topic?: The clinical durations of sporadic Creutzfeldt-Jacob disease (sCJD) patients typically do not exceed 2 years, though considerable variation exists. The factors influencing survival...
3.
Xu B, Xiao K, Jia X, Cao R, Liang D, A R, et al.
Alzheimers Res Ther
. 2025 Feb;
17(1):39.
PMID: 39920821
Background: β-synuclein (β-syn), mainly expressed in central nerve system, is one of the biomarkers in cerebrospinal fluid (CSF) and blood for synaptic damage, which has been reported to be elevated...
4.
Wang Y, Chi S, Tian Y, Li X, Zhang H, Xu Y, et al.
Int J Surg
. 2025 Jan;
PMID: 39878177
Background: Integrating comprehensive information on hepatocellular carcinoma (HCC) is essential to improve its early detection. We aimed to develop a model with multi-modal features (MMF) using artificial intelligence (AI) approaches...
5.
Chen C, Dong X
ACS Chem Neurosci
. 2025 Jan;
16(3):281-283.
PMID: 39836971
Neuroinflammation plays a dual role in prion diseases, contributing both to the clearance of misfolded scrapie-like prion protein and to neuropathology through chronic activation of inflammatory pathways. Key mechanisms, including...
6.
Chen C, Feng Y, Yin Z, Pang M, Shi Q, Ma X, et al.
Front Public Health
. 2024 Dec;
12:1416900.
PMID: 39735751
Objectives: To understand the epidemic characteristics of various SARS-CoV-2 variants, we mainly focus on analyzing general epidemic profiles, viral mutation, and evolution of COVID-19 outbreaks caused by different SARS-CoV-2 variants...
7.
Feng Y, Chen S, Wang A, Zhao Z, Chen C
Front Public Health
. 2024 Dec;
12:1491623.
PMID: 39635220
Objective: The global sharing of pathogen genome sequences has been significantly expedited by the COVID-19 pandemic. This study aims to elucidate the global landscape of SARS-CoV-2 genome sharing between 2020...
8.
Jia X, Chen C, Hu C, Wu Y, Chao Z, Zeng J, et al.
Mol Neurobiol
. 2024 Oct;
62(4):4435-4451.
PMID: 39453517
Prion diseases are fatal neurodegenerative disorders characterized by neuron damage and loss. Growth-associated protein 43 (GAP43) functions in neuronal plasticity and synaptic function, but its role in prion diseases is...
9.
Gao L, Tian T, Xiao K, Chen C, Zhou W, Liang D, et al.
Front Public Health
. 2024 Jun;
12:1411489.
PMID: 38939567
Introduction: Human prion disease (PrD), a group of fatal and transmissible neurodegenerative diseases, consists of Creutzfeldt-Jakob disease (CJD), kuru, fatal familial insomnia (FFI), Gerstmann-Sträussler-Scheinker disease (GSS), and variably protease-sensitive prionopathy...
10.
Feng Y, Su Q, Li L, He X, Niu P, Guo X, et al.
China CDC Wkly
. 2024 May;
6(15):324-331.
PMID: 38736991
Introduction: In the first half of 2023, a global shift was observed towards the predominance of XBB variants. China faced a significant epidemic between late 2022 and early 2023 due...